Collegium Pharmaceutical, Inc.

COLL

NASDAQ

Healthcare

Drug Manufacturers - Specialty & Generic

Stoughton, MA, US357 employeescollegiumpharma.com

$32.27

-0.97(-2.93%)

Mkt Cap $1.0B

$24.67

$49.84

52-Week Range

At a Glance

AI-generated

Revenue breakdown: Belbuca (31.1%), Xtampza ER (28.7%), Nucynta IR (16.4%).

8-K

Collegium Pharmaceutical entered into an Equity Purchase Agreement dated March 19, 2026, to acquire the AZSTARYS ADHD business from Corium Therapeutics Holdings, LLC and Corium, LLC for $650 million in cash, subject to adjustments, plus up to $135 million in regulatory and commercial milestones. The transaction, expected to close in Q2 2026 pending HSR clearance, adds a complementary ADHD product with patents into 2037 and is projected to generate over $50 million in H2 2026 pro forma net revenue while being immediately accretive to adjusted EBITDA.

$1.0B

Market Cap

$782M

Revenue

$63M

Net Income

Employees357

Fundamentals

How The Business Makes Money

Revenue by Segment

Belbuca31.1%($615M)

Xtampza ER28.7%($568M)

Nucynta IR16.4%($324M)

Nucynta ER12.1%($239M)

Jornay Pm9.4%($186M)

Symproic And Other2.3%($46M)

Activity

What Changed Recently

Material Agreement

Mar 18, 2026

Entry into a Material Definitive Agreement. Equity Purchase Agreement On March 19, 2026, Collegium Pharmaceutical, Inc. (the “ Company ”), entered into an Equit

Financial Results

Feb 25, 2026

of this Current Report on Form 8-K. Item 7.01 Regulation FD Disclosure. On February 26, 2026, Collegium Pharmaceutical, Inc. released an earnings presentation.

Regulation FD

Jan 7, 2026

of this Current Report on Form 8-K. To the extent that the information in this Current Report on Form 8-K, including Exhibits 99.1 and 99.2 furnished herewith,

Peer Companies

Company	Price	Change	Market Cap	P/E
DVAXDVAX	$15.50	+0.00%	$1.8B	—
PLSEPulse Biosciences, Inc.	$23.03	+0.04%	$1.6B	-19.4
NKTRNektar Therapeutics	$77.01	+1.72%	$1.6B	-9.2
INVAInnoviva, Inc.	$23.02	-1.64%	$1.5B	6.0
PCRXPacira BioSciences, Inc.	$22.75	-0.20%	$979M	136.8
CRONCronos Group Inc.	$2.54	+1.00%	$975M	-102.5
AMPHAmphastar Pharmaceuticals...	$20.44	+0.99%	$939M	9.0
ATAIAtai Beckley N.V	$3.77	+1.89%	$711M	-1.6

Analyst View

Company Profile

CIK0001267565

ISINUS19459J1043

CUSIP19459J104

Phone781 713 3699

Address100 Technology Center Drive, Stoughton, MA, 02072, US

SEC EDGAR